John C. Davis
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About John C. Davis
John C. Davis was last confirmed as Board Member at Dianthus Therapeutics, Inc. /DE/ (DNTH) in a filing dated April 21, 2021. The proxy statement of Dianthus Therapeutics, Inc. /DE/ reports total compensation of $1,762,160 for John C. Davis in fiscal 2020, including a base salary of $445,376. Disclosed compensation is on record for 2 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2021-04-21
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Jr., M.D. Head of Research and Development and Chief Medical Officer | $445,376 | $1,762,160 |
| 2019 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Jr., M.D. Head of Research and Development and Chief Medical Officer | $417,000 | $913,521 |
Recent activity
No call appearances or filed executive changes recorded yet.